Tachykinin Antibodies

Santa Cruz Biotechnology delivers a wide array of Tachykinin monoclonal antibodies for studying tachykinins, a family of neuropeptides involved in various physiological processes, including pain perception, inflammation, and neurogenic responses. Tachykinin monoclonal antibodies are suitable for research applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tachykinins, including substance P and neurokinin A, are involved in the modulation of neurotransmission and are implicated in several pathophysiological conditions, making them significant targets for therapeutic intervention. The diverse functions of tachykinins in the central and peripheral nervous systems highlight their importance in both normal physiology and disease states. Understanding tachykinins can provide insights into potential treatment strategies for pain and other related disorders. Tachykinin monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms. Researchers worldwide rely on tachykinin monoclonal antibodies to advance scientific understanding of neurological processes. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that contributes to advancing therapeutic developments in neuroscience.